In obesity with T2DM, biliopancreatic diversion increased T2DM remission vs. medical and lifestyle therapy at 10 y

Shohinee Sarma; Lorraine L Lipscombe

doi:10.7326/ACPJ202106150-070

In obesity with T2DM, biliopancreatic diversion increased T2DM remission vs. medical and lifestyle therapy at 10 y

Ann Intern Med. 2021 Jun;174(6):JC70. doi: 10.7326/ACPJ202106150-070. Epub 2021 Jun 1.

Authors

Shohinee Sarma¹, Lorraine L Lipscombe¹

Affiliation

¹ University of Toronto, Toronto, Ontario, Canada (S.S., L.L.L.).

PMID: 34058110
DOI: 10.7326/ACPJ202106150-070

Abstract

Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397:293-304. 33485454.

Publication types

Comment

MeSH terms

Bariatric Surgery*
Biliopancreatic Diversion* / adverse effects
Blood Glucose
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Follow-Up Studies
Humans
Life Style
Obesity / complications
Obesity / therapy
Remission Induction
Weight Loss

Substances

Blood Glucose